Immunology Market Size, Share, Growth, and Industry Analysis, By Type (Immuno Boosters, Immunosuppressants), By Application (Autoimmune Diseases, Oncology, Organ Transplantation, Others), Regional Insights and Forecast From 2026 To 2035

Detailed TOC of Global Immunology Market Research Report 2035

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunology Market Size Growth Rate by Type: 2018 VS 2022 VS 2035
1.2.2 Immuno Boosters
1.2.3 Immunosuppressants
1.3 Market by Application
1.3.1 Global Immunology Market Growth by Application: 2018 VS 2022 VS 2035
1.3.2 Autoimmune Diseases
1.3.3 Oncology
1.3.4 Organ Transplantation
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunology Market Perspective (2018-2035)
2.2 Immunology Growth Trends by Region
2.2.1 Global Immunology Market Size by Region: 2018 VS 2022 VS 2035
2.2.2 Immunology Historic Market Size by Region (2018-2023)
2.2.3 Immunology Forecasted Market Size by Region (2024-2035)
2.3 Immunology Market Dynamics
2.3.1 Immunology Industry Trends
2.3.2 Immunology Market Drivers
2.3.3 Immunology Market Challenges
2.3.4 Immunology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunology Players by Revenue
3.1.1 Global Top Immunology Players by Revenue (2018-2023)
3.1.2 Global Immunology Revenue Market Share by Players (2018-2023)
3.2 Global Immunology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunology Revenue
3.4 Global Immunology Market Concentration Ratio
3.4.1 Global Immunology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunology Revenue in 2022
3.5 Immunology Key Players Head office and Area Served
3.6 Key Players Immunology Product Solution and Service
3.7 Date of Enter into Immunology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunology Breakdown Data by Type
4.1 Global Immunology Historic Market Size by Type (2018-2023)
4.2 Global Immunology Forecasted Market Size by Type (2024-2035)
5 Immunology Breakdown Data by Application
5.1 Global Immunology Historic Market Size by Application (2018-2023)
5.2 Global Immunology Forecasted Market Size by Application (2024-2035)
6 North America
6.1 North America Immunology Market Size (2018-2035)
6.2 North America Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2035
6.3 North America Immunology Market Size by Country (2018-2023)
6.4 North America Immunology Market Size by Country (2024-2035)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunology Market Size (2018-2035)
7.2 Europe Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2035
7.3 Europe Immunology Market Size by Country (2018-2023)
7.4 Europe Immunology Market Size by Country (2024-2035)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunology Market Size (2018-2035)
8.2 Asia-Pacific Immunology Market Growth Rate by Region: 2018 VS 2022 VS 2035
8.3 Asia-Pacific Immunology Market Size by Region (2018-2023)
8.4 Asia-Pacific Immunology Market Size by Region (2024-2035)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immunology Market Size (2018-2035)
9.2 Latin America Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2035
9.3 Latin America Immunology Market Size by Country (2018-2023)
9.4 Latin America Immunology Market Size by Country (2024-2035)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunology Market Size (2018-2035)
10.2 Middle East & Africa Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2035
10.3 Middle East & Africa Immunology Market Size by Country (2018-2023)
10.4 Middle East & Africa Immunology Market Size by Country (2024-2035)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Immunology Introduction
11.1.4 AbbVie Revenue in Immunology Business (2018-2023)
11.1.5 AbbVie Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Immunology Introduction
11.2.4 Amgen Revenue in Immunology Business (2018-2023)
11.2.5 Amgen Recent Development
11.3 F. Hoffmann-La Roche
11.3.1 F. Hoffmann-La Roche Company Detail
11.3.2 F. Hoffmann-La Roche Business Overview
11.3.3 F. Hoffmann-La Roche Immunology Introduction
11.3.4 F. Hoffmann-La Roche Revenue in Immunology Business (2018-2023)
11.3.5 F. Hoffmann-La Roche Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Immunology Introduction
11.4.4 Johnson & Johnson Revenue in Immunology Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Bionor Pharma
11.5.1 Bionor Pharma Company Detail
11.5.2 Bionor Pharma Business Overview
11.5.3 Bionor Pharma Immunology Introduction
11.5.4 Bionor Pharma Revenue in Immunology Business (2018-2023)
11.5.5 Bionor Pharma Recent Development
11.6 Celgene
11.6.1 Celgene Company Detail
11.6.2 Celgene Business Overview
11.6.3 Celgene Immunology Introduction
11.6.4 Celgene Revenue in Immunology Business (2018-2023)
11.6.5 Celgene Recent Development
11.7 Cellectar Biosciences
11.7.1 Cellectar Biosciences Company Detail
11.7.2 Cellectar Biosciences Business Overview
11.7.3 Cellectar Biosciences Immunology Introduction
11.7.4 Cellectar Biosciences Revenue in Immunology Business (2018-2023)
11.7.5 Cellectar Biosciences Recent Development
11.8 eFFECTOR Therapeutics
11.8.1 eFFECTOR Therapeutics Company Detail
11.8.2 eFFECTOR Therapeutics Business Overview
11.8.3 eFFECTOR Therapeutics Immunology Introduction
11.8.4 eFFECTOR Therapeutics Revenue in Immunology Business (2018-2023)
11.8.5 eFFECTOR Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details